Cognition Therapeutics to Present at H.C. Wainwright Global Investment Conference

ConferencezervimesineNeutral

AI Analysis

Summary

Cognition Therapeutics' CEO will present at the H.C. Wainwright Global Investment Conference on September 15, 2026, discussing the company's development of zervimesine for Alzheimer's disease and dementia with Lewy bodies.

Importance:2/10

Sentiment:

0.00

neurodegenerativeAlzheimer's diseasedementia with Lewy bodiesclinical-stageconference presentation

Related Companies

$CGTX

Read the original article

Published by GlobeNewswire Pharma on September 8, 2026 11:30 AM

Read Original